Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Clinical trial NCT00572650 · COMPLETED

Trial details

NCT number: NCT00572650
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2007-10-01
Primary completion: 2007-11-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.